当前位置:首页 - 行情中心 - 重药控股(000950) - 财务分析 - 现金流量表

重药控股

(000950)

  

流通市值:95.40亿  总市值:95.40亿
流通股本:17.28亿   总股本:17.28亿

现金流量表

报告期2025-09-302025-06-302025-03-312024-12-31
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金65,602,358,700.942,660,741,820.7820,324,203,721.6490,100,579,625.53
  收到的税费返还--019,160,820.08
  收到其他与经营活动有关的现金1,387,935,328.321,636,159,929.66437,736,013.981,125,832,292.54
  经营活动现金流入小计66,990,294,029.2244,296,901,750.4420,761,939,735.6291,245,572,738.15
  购买商品、接受劳务支付的现金64,046,357,537.842,452,981,236.9621,065,437,084.9384,998,851,220.07
  支付给职工以及为职工支付的现金1,437,480,216.31951,192,706.47649,380,365.312,002,939,492.26
  支付的各项税费1,040,794,159.32723,806,052.69323,651,677.631,456,966,777.87
  支付其他与经营活动有关的现金2,795,927,277.192,442,412,117.2888,007,976.182,973,552,371.09
  经营活动现金流出小计69,320,559,190.6246,570,392,113.3222,926,477,104.0591,432,309,861.29
  经营活动产生的现金流量净额-2,330,265,161.4-2,273,490,362.88-2,164,537,368.43-186,737,123.14
二、投资活动产生的现金流量:
  收回投资收到的现金74,645,860.53--89,517,400
  取得投资收益收到的现金119,038,363.74119,038,363.74-95,895,035.75
  处置固定资产、无形资产和其他长期资产收回的现金净额701,013235,480.4722,701.471,397,020.11
  处置子公司及其他营业单位收到的现金净额399,607.57399,607.57399,607.570
  收到的其他与投资活动有关的现金40,450,520.9219,755,717.841,078,887.1778,445,381.34
  投资活动现金流入小计235,235,365.76139,429,169.621,501,196.21265,254,837.2
  购建固定资产、无形资产和其他长期资产支付的现金206,624,194.56130,917,613.180,342,269.73250,529,897.34
  投资支付的现金-0048,480,000
  质押贷款净增加额-0-0
  取得子公司及其他营业单位支付的现金25,203,347.0223,140,657.1321,988,216.53138,357,534.96
  支付其他与投资活动有关的现金65,171,073.1830,370,442.855,002,194.5510,351,467.76
  投资活动现金流出小计296,998,614.76184,428,713.08107,332,680.81447,718,900.06
  投资活动产生的现金流量净额-61,763,249-44,999,543.46-105,831,484.6-182,464,062.86
三、筹资活动产生的现金流量:
  吸收投资收到的现金32,323,83019,028,83012,348,8301,050,908,745.83
  其中:子公司吸收少数股东投资收到的现金32,323,83019,028,83012,348,8301,050,908,745.83
  取得借款收到的现金17,572,518,985.4811,484,513,993.634,914,737,190.7123,783,676,955.95
  收到其他与筹资活动有关的现金362,070,243.53281,454,140.61261,978,671.91739,812,073.97
  筹资活动现金流入小计17,966,913,059.0111,784,996,964.245,189,064,692.6225,574,397,775.75
  偿还债务支付的现金17,205,788,644.8911,234,408,564.54,891,245,949.2822,902,856,190.21
  分配股利、利润或偿付利息支付的现金903,337,673.06551,495,180.18234,417,915.681,431,367,135.19
  其中:子公司支付给少数股东的股利、利润180,691,927.1446,375,235.723,290,847.98311,279,316.34
  支付其他与筹资活动有关的现金526,162,335.86326,247,058.27220,706,634.391,191,840,339.45
  筹资活动现金流出小计18,635,288,653.8112,112,150,802.955,346,370,499.3525,526,063,664.85
  筹资活动产生的现金流量净额-668,375,594.8-327,153,838.71-157,305,806.7348,334,110.9
五、现金及现金等价物净增加额-3,060,404,005.2-2,645,643,745.05-2,427,674,659.76-320,867,075.1
  加:期初现金及现金等价物余额4,786,982,574.244,786,982,574.244,786,982,574.245,107,849,649.34
  期末现金及现金等价物余额1,726,578,569.042,141,338,829.192,359,307,914.484,786,982,574.24
补充资料:
  净利润-388,988,353.43-401,791,459.73
  资产减值准备-2,991,945.06-613,983,762.51
  固定资产和投资性房地产折旧-122,708,600.9-233,329,033.85
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧-122,708,600.9-233,329,033.85
  无形资产摊销-25,054,788.76-30,189,584.52
  长期待摊费用摊销-31,385,670.99-76,800,645.3
  处置固定资产、无形资产和其他长期资产的损失--1,202,756.45--10,534,476.58
  固定资产报废损失----12,467.97
  公允价值变动损失-861,030.74--6,919,028.26
  财务费用-379,653,270.8-1,137,829,179.76
  投资损失--58,201,620.47--402,412,494.38
  递延所得税--26,032,430.08--96,496,331.85
  其中:递延所得税资产减少--24,964,750.86--110,203,746.04
    递延所得税负债增加--1,067,679.22-13,707,414.19
  存货的减少--315,335,259.71--1,432,255,263.76
  经营性应收项目的减少--3,335,799,063.08--1,662,828,988.31
  经营性应付项目的增加-711,018,620.83-728,597,767.63
  其他--299,209,682.74--
  现金的期末余额-2,141,338,829.19-4,786,982,574.24
  减:现金的期初余额-4,786,982,574.24-5,107,849,649.34
  加:现金等价物的期末余额-0--
  减:现金等价物的期初余额-0--
  现金及现金等价物的净增加额--2,645,643,745.05--320,867,075.1
公告日期2025-10-282025-08-212025-04-242025-04-24
审计意见(境内)标准无保留意见
TOP↑